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Antinociceptive7-Epiclusianone, a natural prenylated benzophenone, was extracted from Garcinia brasiliensis Planch. & Tri-
ana (Clusiaceae), a native plant commonly known as bacupari and used in traditional Brazilian medicine
for the treatment of inﬂammatory diseases. As a result of the wide spectrum of biological activities attributed
to polyisoprenylated benzophenones, the aim of this study was to evaluate the analgesic and anti-inﬂamma-
tory effects of 7-epiclusianone using two animal models. Carrageenan-induced paw oedema and peritonitis
were used to investigate the anti-inﬂammatory activity of 7-epiclusianone in rats. The acetic acid-induced
writhing, formalin and hot-plate tests were used to investigate its antinociceptive activity in mice. At test
doses of 5, 10 and 15 mg/kg p.o., 7-epiclusianone had an anti-inﬂammatory effect as demonstrated by the re-
duction of paw oedema induced by carrageenan and the inhibition of leukocyte recruitment into the perito-
neal cavity. At the same doses, 7-epiclusianone inhibited nociception induced by an intraperitoneal injection
of acetic acid, observed by the decrease in the number of writhing episodes. Additionally, 7-epiclusianone de-
creased licking time caused by a subplantar injection of formalin. Moreover, the hot plate test produced a sig-
niﬁcant increase in latency reaction, demonstrating an antinociceptive effect. The experimental data
demonstrated that the polyisoprenylated benzophenone 7-epiclusianone has remarkable anti-inﬂammatory
and antinociceptive activities.lfenas, Faculadade de Ciências
ntro, Alfenas-MG, 37130-000,
s Santos).
vier OA license.© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Pain is a common symptom of various inﬂammatory diseases and
is the primary reason why patients pursue specialised treatment
(Silva et al., 2010). Thus, there is a great demand for more effective
anti-inﬂammatory drugs (Newman and Cragg, 2007). Because cur-
rently available anti-inﬂammatory drugs have considerable side ef-
fects that inhibit their clinical use, many studies are currently
underway to develop new treatments for inﬂammatory diseases
(Shukla et al., 2010). The search for alternatives to current treatments
is necessary and will greatly beneﬁt those afﬂicted with inﬂammatory
diseases (Vasudevan et al., 2007). Natural products have been one of
the most successful sources for the discovery of new therapeutic
agents (Harvey, 2000).
The pharmacological study of polyisoprenylated benzophenones
has been shown to be of interest due to the wide spectra of biologicalactivities attributed to its derivates (Coelho et al., 2008). These com-
pounds, isolated from plants of the Clusiaceae family, have been
shown to have antioxidant, cytotoxic, antimicrobial, antiviral and
anti-inﬂammatory properties (Acuña et al., 2009).
7-Epiclusianone, a natural prenylated benzophenone ﬁrst isolated
from the fruits of Garcinia gardneriana (Santos et al., 1999), was
extracted from Garcinia brasiliensis Planch. & Triana (syn. Rheedia bra-
siliensis) (Clusiaceae). This native plant, commonly known as bacu-
pari, has been used in traditional Brazilian medicine for the
treatment of tumours, inﬂammation of the urinary tract, arthritis
and pain (Corrêa, 1978). It has been shown that 7-epiclusianone ex-
hibits activity against trypomastigotes of Trypanosoma cruzi in vitro
(Almeida-Alves et al., 1999). Potent endothelium vasodilator effects
(Cruz et al., 2006) and antianaphylactic (Neves et al., 2007), anti-HIV
(Piccinelli et al., 2005), antimicrobial (Almeida et al., 2008; Murata
et al., 2008, 2010a; Naldoni et al., 2009), antispasmodic (Coelho
et al., 2008), antiproliferative (Murata et al., 2010b) and leishmanici-
dal activities have also been attributed to this benzophenone (Pereira
et al., 2010).
While many studies are underway to determine the chemical
composition and antinociceptive and anti-inﬂammatory activities of
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2011), the aim of this study was to evaluate the analgesic and anti-in-
ﬂammatory proprieties of 7-epiclusianone isolated from this species
using animal models.
2. Materials and methods
2.1. Plant material
The leaves of G. brasiliensis were collected from trees grown under
controlled conditions at the herbarium of the University of Viçosa (lat-
itude 20°45′14″ south and longitude 42°52′55″ west), Minas Gerais,
Brazil, and a voucher specimen has been deposited (number VIC2604).
2.2. Extraction and isolation procedures
To obtain the extract, the leaves were dried, powdered (1 kg) and
extracted with n-hexane in Soxhlet equipment for 24 h. The solvent
was removed under reduced pressure and then dried with a spray
dryer (BÜCHI Mini Spray Dryer B-290). The yield of the G. brasiliensis
hexane extract (GbHE) was 8.5%. To isolate the bioactive compound,
GbHE was chromatographed on a silica gel (230–400 mesh) column
(8×100 cm) and eluted with crescent polarity mixtures of n-hexane/
ethyl-acetate and ethyl-acetate/ethanol to give 25 fractions. These frac-
tions were pooled into four groups according to their similarities
after the analysis using thin layer chromatography (TLC) and compared
to the standard 7-epiclusianone previously isolated from hexane ex-
tracts of the fruit of G. brasiliensis. Fractions 4–10 were rechromato-
graphed on a silica gel (230–400 mesh) column (8×100 cm) and
eluted with crescent polarity mixtures of n-hexane/ethyl-acetate
and ethyl-acetate/ethanol to purify the prenylated benzophenone 7-
epiclusianone (Fig. 1). Its structurewas determined using spectroscopic
techniques (IR, UV, MS and 1H and 13C NMR). The data were compared
to those veriﬁed in a previous study investigating the chemical struc-
ture of this compound (Derogis et al., 2008; Santos et al., 1998, 1999).
2.3. Pharmacological procedures
2.3.1. Animals
Adult male Wistar rats, weighing 180 to 220 g, and adult male
Swiss mice, weighing 28 to 32 g, were obtained from the Central Ani-
mal Facility of the Federal University of Alfenas-MG and housed under
controlled light (12:12 h light–dark cycle; lights on at 06:00 am) and
temperature conditions (23±1 °C) with access to water and food adFig. 1. Chemical structure of 7-epiclusianone, a polyprenylated benzophenone.libitum. The animalswere allowed to habituate to the housing facilities
for at least 1 week before the experiments began. All experiments
were conducted in accordance with the Declaration of Helsinki on
the welfare of experimental animals and with the approval of the
Ethics Committee of the Federal University of Alfenas-MG (234/2009).
2.3.2. Preparation of the test samples for the bioassay
7-Epiclusianone was dissolved in vehicle (soybean oil) and ad-
ministered orally to animals in the test groups at doses of 5, 10 and
15 mg/kg. Animals in the control group received the same experi-
mental handling as those in the test groups, except that the drug
treatment was replaced by appropriate volumes of the vehicle. Indo-
methacin (10 mg/kg, p.o.) was diluted in Tris buffer (pH 8.5) and
morphine sulphate (1 or 10 mg/kg, i.p.) was diluted in sterile saline
(0.9% NaCl).
2.3.3. Evaluation of anti-inﬂammatory activity in rats
2.3.3.1. Carrageenan-induced rat paw oedema. Pedal inﬂammation in
rats was produced as described previously (Vinegar et al., 1969), fol-
lowing an overnight fast with free access to water. Paw oedema was
measured using a plethysmometer (Model 7140, Ugo Basile, Italy).
The basal volume of the right hind paw was determined before the
administration of any drug. After determination of the basal volume,
the animals (n=8 per group) were divided into experimental groups
in such a way that the mean volumes of the different groups were
similar. Vehicle, 7-epiclusianone or indomethacin was orally adminis-
tered 1 h before the intraplantar (i.pl.) injection of carrageenan (1 mg,
100 μl). The paw volume was measured 1, 2, 3 and 4 h after the injec-
tion of the inﬂammatory stimulus. The results are presented as the
paw volume (ml) variation normalised to the basal values.
2.3.3.2. Peritonitis induced by lipopolysaccharide. To assess the possible
effect of the benzophenone on leukocyte recruitment to the peritone-
al cavity, the animals (n=8 per group) were orally pre-treated with
vehicle, 7-epiclusianone or indomethacin, and 30 min later, lipopoly-
saccharide (LPS) from Escherichia coli serotype 026:B6 dissolved in
pyrogen-free sterile saline was administered at a dose of 500 μg/kg
i.p. Four hours after the injection of LPS, rats were killed with an inha-
latory overdose of halothane, and the cells from the peritoneal cavi-
ties were harvested by an injection of 10 ml of PBS containing 0.5%
sodium citrate. The abdomens were gently massaged, and the
blood-free cell suspension was carefully aspirated with a syringe. Ab-
dominal washings were placed into plastic tubes, and total cell counts
were performed immediately in a Neubauer chamber (Cunha et al.,
1989).
2.3.4. Evaluation of antinociceptive activity in mice
2.3.4.1. Acetic acid-induced writhing in mice. Acetic acid (0.6% v/v,
10 ml/kg) was injected into the peritoneal cavities of mice, which
were placed in a large glass cylinder, and the intensity of their noci-
ceptive behaviour was quantiﬁed by counting the total number of
writhes occurring between 0 and 20 min after stimulus injection, as
described previously (Collier et al., 1968). Oral treatment with vehi-
cle, indomethacin or 7-epiclusianone was given 1 h prior to acetic
acid injection (n=6 per group). Morphine was intraperitoneally ad-
ministered 30 min before the test. The writhing response consisted
of a contraction of the abdominal muscles together with a stretching
of the hind limbs. The antinociceptive activity was expressed as the
writhing scores over a period of 20 min.
2.3.4.2. Formalin-induced nociception. A formalin solution (5% in 0.9%
saline) was injected (20 μl/paw) into the hind paw plantar surface
(i.pl.), and the animals were individually placed in transparent obser-
vation chambers, as previously described (Santos and Calixto, 1997;
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Fig. 3. Effects of the administration of 7-epiclusianone (p.o.), indomethacin (INDO)
(10 mg/kg, p.o.) or vehicle (10 ml/kg, p.o.) on lipopolysaccharide-induced recruitment
of leukocytes to the peritoneal cavity of rats. Each column represents the mean±S.E.M.
of eight animals per group. ***Pb0.001 compared with the saline+vehicle group.
###Pb0.01; ##Pb0.01; #Pb0.05 compared with vehicle+LPS group.
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Fig. 2. Effects of the administration of 7-epiclusianone (p.o.), indomethacin (10 mg/kg,
p.o.) or vehicle (10 ml/kg, p.o.) on rat paw oedema induced by intraplantar carrageenan
injection (1 mg/paw). Each point represents the mean±S.E.M. of eight animals per
group. The asterisks denote the signiﬁcance levels when compared with the control
group: **Pb0.01, ***Pb0.001.
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or 7-epiclusianone were given 1 h prior to formalin injection (n=8
per group). Morphine was administrated (i.p.) 30 min before the
test. The time spent licking the injected paw was recorded and
expressed as the total licking time in the early phase (0–5 min) and
late phase (20–30 min) after the formalin injection.
2.3.4.3. Hot plate test. The hot plate consisted of an electrically heated
surface kept at a constant temperature of 50.0±0.5 °C. Mice were
placed on the heated surface within Plexiglas walls to constrain
their locomotion on the plate, and the latency to a discomfort reaction
(licking of the paws or jumping) was recorded 0, 30, 60 and 120 min
after oral administration of vehicle, 7-epiclusianone or morphine
(n=8 per group), with a reaction time of zero minutes signifying
the start of the test. A cut-off time of 20 s was chosen to indicate com-
plete analgesia and avoid tissue injury. The latencies for paw licking
or jumping were recorded for each animal.
Trying to elucidate the mechanism by which 7-epiclusianone in-
duces antinociception, animals were pre-treated with naloxone
15 min before morphine (1 mg/kg) or 7-epiclusianone (10 mg/kg)
treatment (Couto et al., 2011).
2.3.5. Open-ﬁeld test
To discard the possible nonspeciﬁc effects of muscle relaxants or
the sedative effects of the polyprenylated benzophenone, the motor
performance of the mice was evaluated on the open-ﬁeld apparatus
(Archer, 1973). Groups of mice (n=6) were treated with vehicle or
7-epiclusianone 1 h before the test. Each animal was placed in the
centre of the open-ﬁeld arena and allowed free ambulation for
5 min to observe the locomotion frequency (number of ﬂoor units
the animal entered with all of its limbs) (Milano et al., 2008).
2.4. Statistical analysis
The data obtained were analysed using GraphPad software
programme version 4.0 and expressed as the mean±S.E.M.
Statistically signiﬁcant differences between groups were calculated
by the application of an analysis of variance (ANOVA) followed
by the Newman–Keuls test. P-values less than 0.05 (Pb0.05) were
considered signiﬁcant.
3. Results
3.1. Carrageenan-induced rat paw oedema
The benzophenone signiﬁcantly inhibited carrageenan-induced
rat paw oedema (F4,39=4.39; P=0.0004). The inhibitory values of
oedema at 3 h post-carrageenan treatment were 57.7, 58.9 and
53.2% for 5, 10 and 15 mg/kg of the compound, respectively. Indo-
methacin (10 mg/kg) gave a percentage inhibition of 44.7% (Fig. 2).
At 4 h post-carrageenan treatment, the inhibitory values of oedema
were 67.6, 54.1 and 59.5% for 5, 10 and 15 mg/kg of the compound,
respectively. Indomethacin (10 mg/kg) gave a percentage inhibition
of 56.8% (Fig. 2).
3.2. Peritonitis induced by lipopolysaccharide
In agreement with previous studies, LPS-induced peritonitis was
followed by a signiﬁcant increase in the number of leukocytes in the
peritoneal cavity of rats when compared to the vehicle-treated con-
trol group (Cunha et al., 1989). 7-Epiclusianone signiﬁcantly inhibited
leukocyte recruitment to the peritoneal cavity in rats (F5,37=10.05;
Pb0.001). The inhibitory values of leukocyte recruitment at 4 h
post-LPS were 53.5 and 72.9% for 10 and 15 mg/kg of the compound,
respectively. Indomethacin (10 mg/kg) gave a percent inhibition of
82.7% (Fig. 3).3.3. Acetic acid-induced writhing in mice
The oral administration of 7-epiclusianone (5, 10 and 15 mg/kg)
caused a signiﬁcant reduction (F5,41=37.45; Pb0.001) in the number
of writhing episodes induced by acetic acid compared to the control
by 16.9, 43.70 and 73.6%, respectively. Indomethacin and morphine
produced 61.31 and 89.6% reductions in acetic acid-induced writhing
movements, respectively, compared to the control (Fig. 4).
3.4. Formalin test in mice
The benzophenone at doses of 5 to 15 mg/kg p.o. had a signiﬁcant
antinociceptive activity compared to the control in both the early
(F5,63=19.86; Pb0.001) and late phases (F5,63=8.18; Pb0.001) of
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Fig. 4. Effects of 7-epiclusianone on acetic acid-induced writhing movements in mice.
Animals were pretreated with 7-epiclusianone (p.o.), indomethacin (10 mg/kg p.o.),
morphine (10 mg/kg i.p.) or vehicle (10 ml/kg, p.o.) prior to the administration of
acetic acid (0.6%, i.p.). Each column represents the mean±S.E.M. for six mice per
group. The asterisks denote the signiﬁcance levels when compared with the control
group: *Pb0.05, ***Pb0.001.
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the late phase of the formalin test, while morphine inhibited both
phases of the painful stimulus (Fig. 5).First phase
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Fig. 5. Effects of 7-epiclusianone on the licking induced by a formalin injection in mice.
Animals were pretreated with 7-epiclusianone (p.o.), indomethacin (INDO) (10 mg/kg,
p.o.), morphine (MORP) (10 mg/kg, i.p.) or vehicle (10 ml/kg, p.o.) prior to formalin in-
jection. The total time spent licking the hind paw was measured in the early (Panel A)
and late (Panel B) phases after intraplantar injection of formalin. Each column repre-
sents the mean±S.E.M. for eight mice per group. The asterisks denote the signiﬁcance
levels when compared with the control group: ***Pb0.001.3.5. Hot plate test in mice
7-Epiclusianone, administrated at doses of 5 to 15 mg/kg, increased
the latency time compared to the control group at 30 (F4,50=6.11;
P=0.005) and 60 min (F4,50=4.49; P=0.0038). Morphine, which was
used as standard drug, also signiﬁcantly increased the latency time
(Fig. 6A). The naloxone completely blocked (F4,34=24.1; P b0.001)
the morphine antinociceptive effect and also blocked the antinocicep-
tive activity of the 7-epiclusianone at 10 mg/kg dose (Fig. 6B).
3.6. Open-ﬁeld test
Mice treated with the benzophenone at 5 to 15 mg/kg did not
demonstrate a statistical reduction in the number of crossings and0
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Fig. 6. Effects of 7-epiclusianone on the hot plate test. Panel A— animals were pretreated
with vehicle (10 ml/kg, p.o.), 7-epiclusianone (p.o.) ormorphine (10 mg/kg, i.p.) or prior to
the tests at 50 °C. Panel B— animals were treatedwith vehicle+morphine (1 mg/kg), Ve-
hicle+7-epiclusianone (10 mg/kg), naloxone+morphine (NLX+morphine; 0.4 mg and
1 mg, respectively) or naloxone+7-epiclusianone (NLX+7-epiclusianone; 0.4 mg and
10mg, respectively) prior to the tests at 50 °C. Each column represents the mean with S.
E.M. for eight mice in each group. The symbols denote the signiﬁcance levels:
*Pb0.05 when compared with the time zero; #Pb0.05 when compared with the vehicle+
7-epiclusianone group, †Pb0.05 when compared with the morphine group.
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(data not shown).
4. Discussion
Considering the studies already described and the wide spectra of
biological activities of the polyisoprenylated benzophenones, we eval-
uated the anti-inﬂammatory and analgesic activity of 7-epiclusianone
using animal models of pain behaviour.
For the screening of compounds possessing anti-inﬂammatory ac-
tivity, carrageenan-induced paw oedema is a model widely employed
and has frequently been used to assess the anti-oedematogenic effect
of natural products (Mendes et al., 2010). Carrageenan has also
been used as a noxious agent to induce experimental inﬂammation,
which is discernible within 30 min after local injection into the rat
paw (Ojewole, 2006). The development of oedema induced by carra-
geenan is a biphasic event. The early phase (1–2 h) is mainly mediat-
ed by histamine, serotonin and bradykinin. The late phase is sustained
by the release of prostaglandins and nitric oxide, with a peak at 3 h,
and is produced by inducible isoforms of cyclooxygenase (COX-2)
and nitric oxide synthase (iNOS) (Brito and Antonio, 1998; Seibert
et al., 1994). Previous oral treatment with this benzophenone was ef-
fective in reducing the oedematogenic response evoked by carrageen-
an in late phase. This reduction may be caused by inhibition of one or
more intracellular signalling pathways involved in mediating the in-
ﬂammatory response (Thomazzi et al., 2010).
Although leukocytes have a protective role in inﬂammation, tissue
damage is a deleterious consequence of the intense migration of neu-
trophils, as observed in immune inﬂammatory diseases (Smiderle
et al., 2008). To conﬁrm the probable anti-inﬂammatory activity of
7-epiclusianone, a test using LPS-induced peritonitis was performed.
Lipopolysaccharides bind to toll-like receptors (TLR4) present in
phagocytic cells and promote the production of pro-inﬂammatory cy-
tokines and leukocyte migration (Dantzer, 2009). In the peritonitis
test, our results demonstrated that 7-epiclusianone signiﬁcantly re-
duced leukocyte migration to the peritoneal cavity, showing that
this compound has active anti-inﬂammatory properties.
The formalin test is a model that consists of two distinct phases.
The ﬁrst phase, or neurogenic phase (immediately after formalin in-
jection), seems to be caused by the direct effect of formalin on sensory
C-ﬁbres. The second phase, or inﬂammatory phase (starting approxi-
mately 20 min after injection), is associated with the development of
an inﬂammatory response and the release of nociceptive mediators
(Abbott et al., 1995; Davidson and Carlton, 1998). It was reported
that substance P and bradykinin participate in the appearance of the
early phase responses and that histamine, serotonin, prostaglandin
and bradykinin are involved in the late phase responses (Du et al.,
2007). Centrally acting drugs, such as opioids, inhibit both phases
equally, while peripherally acting drugs, such NSAIDs and corticoste-
roids, only inhibit the late phase (Shibata et al., 1989). Our results
demonstrate that 7-epiclusianone shows analgesia in the early and
late phases of the formalin test, suggesting that 7-epiclusianone acts
both centrally and peripherally to reduce inﬂammatory pain.
A reduction of the late phase behavioural response to an i.p. for-
malin injection was observed, demonstrating the anti-inﬂammatory
activity produced by 7-epiclusianone. The results obtained from carra-
geenan-induced rat paw oedema and peritonitis induced by lipopoly-
saccharide also conﬁrmed this effect. Likewise, other benzophenones
have been shown to possess anti-inﬂammatory activities. Garcinol
modulates arachidonic acid metabolism in LPS-stimulated murine
macrophages and suppresses iNOS and COX-2 expression and NO
formation (Hong et al., 2006). Additionally, 3′4,5′,6-tetrahydroxy-
2-O-β-D-xylosylbenzophenone and 3′4,5′,6-tetrahydroxy-2-O-(4-
O-acetyl-β-D-Xylosyl) have been shown to suppress the oxidative
burst of neutrophils (Demirkiran et al., 2009). Additionally, the ben-
zophenone N-ethyl piperidine ether analogues have been shown tohave a signiﬁcant anti-inﬂammatory proﬁle, mainly against the leu-
kocyte inﬁltration measured in the carrageenan paw oedema test
(Khanum et al., 2009).
Similar to other substances that act on the central nervous system
(CNS), 7-epiclusianone inhibited both phases of the formalin test in a
manner similar to that of morphine. Moreover, the results of this test
are in agreement with those obtained from the hot plate test, con-
ﬁrming the central antinociceptive effect of the compound.
The acetic acid-induced writhing test is a visceral pain model
widely used to screen potential analgesic substances. In this model,
pain is generated indirectly via endogenous mediators, such as brady-
kinin, serotonin, histamine, substance P and prostaglandins, which
stimulate peripheral nociceptive neurons that are sensitive to narcot-
ic analgesics and non-steroidal anti-inﬂammatory drugs (NSAIDs)
(Collier et al., 1968; Derardt et al., 1980). Moreover, these mediators
are able to increase vascular permeability, reduce the threshold of
nociception and stimulate the nerve terminals of nociceptive ﬁbres
(Martinez et al., 1999). Intraperitoneally injected acetic acid can
also directly activate non-selective cation channels located at primary
afferent pathways (Julius and Basbaum, 2001).
The results obtained in this study revealed that 7-epiclusianone
signiﬁcantly reduced acetic acid-induced writhing responses, sug-
gesting that 7-epiclusianone may reduce the liberation of inﬂamma-
tory mediators or block inﬂammation-promoting receptors. Neves
et al. (2007) suggested that benzophenones might also block Ca2+ in-
ﬂux and/or intracellular Ca2+-dependent mechanisms, so this possi-
bility must be also be considered.
The acetic acid-induced writhing test is a nonspeciﬁc model (i.e.,
anticholinergic, tricyclic antidepressants, antihistamines and other
agents show activity in this test) (Queiroz et al., 2010); thus, other
tests, such as the formalin and hot-plate tests, need to be conducted
before any conclusion can be made regarding the mechanism of anti-
nociceptive activity (Zakaria et al., 2010).
The hot plate test speciﬁcally tests for central antinociception
(Vilela et al., 2009) and measures complex responses to inﬂammation
and nociception (Bhandare et al., 2010). The rapid effect with a max-
imum peak observed shortly after administration of 7-epiclusianone
is similar to the time course of action of opioid agonists (e.g., mor-
phine, fentanyl and etorphine) that mediate analgesia by central
mechanisms (Pinheiro et al., 2010) involving supraspinal compo-
nents (Yaksh and Rudy, 1976, 1977; Yeung et al., 1977).
One of themain strategies in nociception studies has been the search
for opioid analgesics acting at opioid receptors outside the central ner-
vous system (CNS), with the prospect of avoiding centrally mediated
side effects as tolerance and dependence (Benyhe, 1994; Vanegas and
Tortorici, 2002). For the assessment of opioid system involvement in
the analgesic activity the mice were pre-treated with an opioid an-
tagonist, naloxone. In this study, naloxone prevented the antinocicep-
tive effect of 7-epiclusianone in hot plate tests. Those results suggest
that, at least part of the anti-hyperalgesic effect observed is due to in-
volvement of this system (μ-opioid) since naloxone reverted the antino-
ciceptive activity.
In the present study, we demonstrated the efﬁcacy of 7-epiclusia-
none, a prenylated benzophenone isolated from the leaves of
G. brasiliensis, in different anti-inﬂammatory and antinociceptive
tests. These effects occurred at doses that evoked no visible modiﬁ-
cations in the overall behaviour of the animals. However, further
studies should be conducted to investigate the molecular mecha-
nisms of action of this benzophenone and its participation in the
pain inhibitory mechanisms of the CNS.Acknowledgements
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